Quality of life in cutaneous lymphoma patients: patient-reported outcomes

Quality of life in cutaneous lymphoma patients: patient-reported outcomes

VJHemOnc

1 year
111 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Pablo Ortiz, MD, PhD, of the University Hospital 12 of October, Madrid, Spain, speaks at the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland, on the quality of life of patients with cutaneous T-cell lymphoma. Prof. Ortiz expresses his concerns about clinical outcomes and patient expectations as a doctor, and highlights the need to gather more information on patient-reported outcomes to support the decision-making process of doctors.
Up Next Autoplay
Comparative Outcomes of Relapsed Follicular Lymphoma Patients #ASH19 @ClevelandClinic
Comparative Outcomes of Relapsed Follicular Lymphoma Patients #ASH19 @ClevelandClinic
Category: Non-Hodgkin Lymphoma
26 Views
ash 4 weeks
Analysis of Brentuximab Vedotin Plus  CHP (A+CHP) #ASH19 @OfficialUoM
Analysis of Brentuximab Vedotin Plus CHP (A+CHP) #ASH19 @OfficialUoM
Category: Non-Hodgkin Lymphoma
5 Views
ash 1 month
Follow-Up in Relapsed/Refractory MCL #ASH19
Follow-Up in Relapsed/Refractory MCL #ASH19
Category: Non-Hodgkin Lymphoma
20 Views
ash 1 month
Dose Optimization Portion of the Phase 2 PRIMO Study in Relapsed or Refractory PTCL #ASH19 @sloan_kettering
Dose Optimization Portion of the Phase 2 PRIMO Study in Relapsed or Refractory PTCL #ASH19 @sloan_kettering
Category: Non-Hodgkin Lymphoma
31 Views
ash 1 month
KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy #ASH19
KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy #ASH19
Category: Non-Hodgkin Lymphoma
4 Views
ash 1 month
Lymphopenia: How This Affects Clinicians and Treatment Today @CleClinicNews
Lymphopenia: How This Affects Clinicians and Treatment Today @CleClinicNews
Category: Non-Hodgkin Lymphoma
7 Views
Cancer-News 1 month
Immune Status, Inflammation Can Predict Mortality @CleClinicNews @CleClinicMD
Immune Status, Inflammation Can Predict Mortality @CleClinicNews @CleClinicMD
Category: Non-Hodgkin Lymphoma
3 Views
Cancer-News 1 month
Update on Phase I REGN1979 #ASH19 #ASH @RutgersCancer
Update on Phase I REGN1979 #ASH19 #ASH @RutgersCancer
Category: Non-Hodgkin Lymphoma
10 Views
ash 1 month
Epizyme Presents Updated Phase 2 Data at the 2019 ASH Annual Meeting Supporting Planned Tazemetostat NDA Submission for Follicular Lymphoma
Epizyme Presents Updated Phase 2 Data at the 2019 ASH Annual Meeting Supporting Planned Tazemetostat NDA Submission for Follicular Lymphoma
Category: Non-Hodgkin Lymphoma
27 Views
Cancer-News 1 month
Moleculin Announces Positive Trial Data with 100% Safe Delivery of p-STAT3 Inhibitor and Efficacy in Majority of Patients
Moleculin Announces Positive Trial Data with 100% Safe Delivery of p-STAT3 Inhibitor and Efficacy in Majority of Patients
Category: Non-Hodgkin Lymphoma
6 Views
Cancer-News 2 months